You are here: Industry Insights > CDMO

News List

Mallinckrodt invests $100M in its BioVectra CDMO en-cphi.cn
March 08, 2019
The Canadian operations plant where Mallinckrodt makes the API for its controversial—and pricey—H.P. Acthar Gel is expanding and getting some Canadian tax dollars to help with the expense.
Former AstraZeneca UK plant back up for sale, putting 270 jobs at risk fiercepharma
February 20, 2019
A CDMO that has made a habit of snapping up Big Pharma’s discarded manufacturing plants has put a former AstraZeneca plant into bankruptcy.
Novartis Makes Offer for French CDMO contractpharma
December 27, 2018
Novartis has made an offer to acquire CellforCurefrom LFB. CellforCure, a French company, is one of the first and largest contract development and manufacturing organizations (CDMO) producing cell and gene therapies in Europe.
Novartis offers to buy Kymriah manufacturer pharmaphorum
December 24, 2018
Following its success in the burgeoning area of CAR-T therapies, Novartis is looking to strengthen its cell and gene manufacturing capabilities by offering to acquire CDMO CellforCure, manufacturers of its CAR-T drug Kymriah.
Novartis makes offer to acquire French CDMO CellforCure pharmaceutical-technology
December 24, 2018
Novartis has made an offer to acquire CellforCure, a France-based contract development and manufacturing organisation (CDMO) producing cell and gene therapies in Europe, from LFB for an undisclosed amount.....
140 jobs in jeopardy as Recipharm weighs the fate of money-losing plant fiercepharma
December 20, 2018
A Recipharm plant in the U.K. has been on the edge financially for some time, having been unprofitable for three years. Now, the Swedish-based CDMO says the cost of fixing issues raised by U.K. authorities may be the breaking point.
Rentschler Biopharma to Purchase U.S. Manufacturing Site from Shire americanpharmaceuticalreview
December 18, 2018
Rentschler Biopharma announced the company has signed an agreement to purchase a manufacturing facility from an affiliate Shire plc in Milford near Boston, MA......
Lonza to establish new base in China using GE healthcare solution biospectrumasia
December 17, 2018
New biologics facility, scheduled to be operational in 2020, will provide development and manufacturing facilities from early- to late-clinical and early-commercial stages.
Lonza to Establish Bio Mfg. Base in China contractpharma
December 12, 2018
Lonza entered an agreement with GE Healthcareunder which GE will deliver a biologics facility to Lonza in Guangzhou. The facility is part of a larger biomanufacturing initiative between GE Healthcare
Niche CDMO confirms spray drying for highly potent drugs cphi-online
November 15, 2018
Idifarma's GMP spray drying technology for highly potent drugs up to Category 4 OEL/OEB is now operational.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page